Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential seasonal trivalent influenza vaccine and pandemic H1N1 vaccine study in adults aged 61 years and older
2009-014448-13Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluarix and AS03-adjuvanted A/California/7/2009 (H1N1)v-like influenza vaccine in influenza A virus infection (H1N1) and seasonal influenza (3 arms), sponsored by GSK. Primary endpoints: Humoral immune response in terms of HI antibodies, EMEA pandemic influenza vaccine immunogenicity criteria and 1 more. Started Sep 2009; status: completed.
02
Drugs
FluarixAS03-adjuvanted A/California/7/2009 (H1N1)v-like influenza vaccine
03
Conditions
influenza A virus infection (H1N1)seasonal influenza
Beyond the preview
Go deeper on 2009-014448-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014448-13.